Daniel Rodriguez Greve
14Patents
3h-index
28Co-inventors
56Inventor score
Filing activity: Apr 27, 2004 → Jun 8, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7812020B2 | Substituted pyridine derivatives | Human Necessities | 5 | Active |
| US11292799B2 | Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors | Human Necessities | 4 | Active |
| US11384096B2 | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors | Human Necessities | 4 | Active |
| US11981681B2 | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors | Human Necessities | 1 | Active |
| US7067501B2 | Aryloxyphenyl and arylsulfanylphenyl derivatives | Human Necessities | 1 | Expired |
| US7612068B2 | Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives | Chemistry; Metallurgy | 0 | Expired |
| US10851116B2 | Bicyclic amines as novel JAK kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7601870B2 | Substituted aniline derivatives | Chemistry; Metallurgy | 0 | Active |
| US8299071B2 | Substituted pyridine derivatives | Human Necessities | 0 | Active |
| US10799507B2 | 5-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-5-azaspiro[2.5]octane-8-carboxylic acid derivatives as novel JAK kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US9346809B2 | Heterocyclic compounds as JAK receptor and protein tyrosine kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US7683058B2 | Substituted pyrimidine derivatives | Chemistry; Metallurgy | 0 | Active |
| US9586961B2 | Homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof | Human Necessities | 0 | Active |
| US9233964B2 | Sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use therof | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.